Patent · US Active

Antineoplastic combinations

USRE41084E1 · kind E1 · reissue

2Cited by
32References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 22, 2006
Grant dateJan 19, 2010
Priority date
Expiry dateDec 22, 2026

Classification

  • Technology area (CPC —)General

Abstract

This invention provides the use of a combination of CCI-779 and EKB-569 in the treatment of neoplasms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.